DOI: 10.36347/sjams.2022.v10i08.036

Pages: 1384-1388

Introduction: As per updated epidemiology of cancer stomach it ranks fourth after lung, breast and colorectal cancer. The overall prognosis is not very encouraging. The aim of the study was to evaluate the descriptive epidemiological study of gastric cancer patients. Methods: This prospective observational study was conducted at department of Surgical Oncology, National Institute of Cancer Research and Hospital, Mohakhali, Dhaka during July, 2019 to March, 2021. A total of 53 patients were included for the study. Sampling method was purposive non- randomized sampling. Preoperative evaluation included basic laboratory tests such as CBC, RBS, S. creatinine, S. electrolyte, S. albumin, liver function test, ECG, chest x-ray , USG of whole abdomen, contrast CT scan of abdomen and serum CEA. Statistical analysis was performed by using SPSS (statistical package for social sciences) version 28. Prior to the commencement of this study, the research protocol was approved by the Research Review Committee of Department of Surgical Oncology and the Ethical Committee of National Institute of Cancer Research & Hospital, Dhaka. Results: There was no association among postoperative complications of modified D2 gastrectomy with patient’s age, gender and smoking status. The highest 49(92.45%) were experiencing anorexia, 43(81.13%) patients having vomiting and approximately 38(71.69%) patients had dyspepsia. 28(52.83%) were suffering from DM and 24(45.28%) patients were suffering from HTN. Out of 53 patients the highest number of patients 16 (30.19%) suffer from postoperative infection/sepsis. Total number of 7(13.20%), 15(28.30%), 21(39.62%), 3(5.66%) patients had N1, N2, N3a, N3b metastatic lymph nodes respectively. Conclusion: After analyzing the results of present study, it can be concluded that D2 gastrectomy with avoiding pancreatic splenectomy improves postoperative outcomes significantly.